Cordyceps Sunshine Biotech Holdings Co., Ltd. Cash and Cash Equivalents
Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) had Cash and Cash Equivalents of $3.20 thousand as of 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-05-15
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $3.20K.
- 2024-12-31: Cash and Cash Equivalents, at Carrying Value $37.28K.
- 2023-12-31: Cash and Cash Equivalents, at Carrying Value $23.10K; Cash and Cash Equivalents, at Carrying Value as first filed $15.28K.
- 2023-09-30: Cash and Cash Equivalents, at Carrying Value $16.91K.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2025-12-31 | $3.20K 20-F · filed 2026-05-15 | |
| 2024-12-31 | $37.28K 20-F · filed 2026-05-15 | |
| 2023-12-31 | $23.10K 20-F/A · filed 2025-09-23 | $15.28K 20-F · filed 2024-07-05 |
| 2023-09-30 | $16.91K 6-K · filed 2023-11-13 | |
| 2022-12-31 | $6.63K 20-F/A · filed 2025-09-23 | $16.10K 20-F · filed 2023-05-15 |
| 2021-12-31 | $99.68K 20-F · filed 2023-05-15 | |
| 2020-12-31 | $294.00 20-F · filed 2023-05-15 |